GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind,…
Read MoreGW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind,…
Read More